ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the Company in connection with the completion of the Company’s acquisition of ABcann Medicinals Inc. (the “Transaction”). The Transaction included concurrent capital raises of $26.8 million to expand ABcann’s production capacity.
Mr. Wilson’s extensive experience and track record in financing and building early stage ventures into successful companies makes him an ideal strategic advisor to the Company at this stage of its development. Mr. Wilson was a co-founder in 1993 of the highly regarded investment bank, FirstEnergy (which was subsequently acquired by GMP Capital Inc.). He is a leading TV personality, known for his role as a “Dragon” on CBC’s award winning Dragons’ Den television program, and an early-stage venture financier in hundreds of successful companies.
Mr. Wilson’s involvement and $500,000 investment in the Company’s subscription receipt offering undertaken concurrently with the completion of the Transaction represents another major step for Mr. Wilson into the legal cannabis industry. He is also a lead investor and strategic advisor with Green Acre Capital, a Toronto and Calgary based cannabis industry focused investment fund.
“Mr. Wilson is a welcome addition to the Company’s Advisory Board. He’s a widely respected, established, and accomplished business leader and will complement the talents of our directors and advisors. We look forward to utilizing Brett’s knowledge and experiences as we grow the ABcann brand and welcome his personal investment and interest into the Company,” says Aaron Keay, CEO and a director of the Company.
ON BEHALF OF THE BOARD OF DIRECTORS
CEO and Director
For further information, please contact Aaron Keay by phone at (604) 323-6911 or by email email@example.com OR Leo Karabelas by phone at 416 543-3120 or by email firstname.lastname@example.org
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which are statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to the timing of the resumption of trading of the Company’s shares on the TSXV and the expected contributions of Mr. Wilson. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that delays may occur in timing of the resumption of trading and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the filing statement filed by the Company in connection with the Transaction, carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).